These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16163399)

  • 1. Open-label treatment with citalopram in patients with irritable bowel syndrome: a pilot study.
    Masand PS; Gupta S; Schwartz TL; Virk S; Hameed A; Kaplan DS
    Prim Care Companion J Clin Psychiatry; 2005; 7(4):162-6. PubMed ID: 16163399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective serotonin reuptake inhibitors for the treatment of irritable bowel syndrome.
    Bundeff AW; Woodis CB
    Ann Pharmacother; 2014 Jun; 48(6):777-84. PubMed ID: 24651166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paroxetine in Patients With Irritable Bowel Syndrome: A Pilot Open-Label Study.
    Masand PS; Gupta S; Schwartz TL; Virk S; Lockwood K; Hameed A; King M; Kaplan DS
    Prim Care Companion J Clin Psychiatry; 2002 Feb; 4(1):12-16. PubMed ID: 15014729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Open-Label Pilot Study of Duloxetine in Patients With Irritable Bowel Syndrome and Comorbid Major Depressive Disorder.
    Lewis-Fernández R; Lam P; Lucak S; Galfalvy H; Jackson E; Fried J; Rosario M; de la Cruz AA; Sánchez-Lacay A; Díaz S; Schneier F
    J Clin Psychopharmacol; 2016 Dec; 36(6):710-715. PubMed ID: 27755218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressant therapy (imipramine and citalopram) for irritable bowel syndrome: a double-blind, randomized, placebo-controlled trial.
    Talley NJ; Kellow JE; Boyce P; Tennant C; Huskic S; Jones M
    Dig Dis Sci; 2008 Jan; 53(1):108-15. PubMed ID: 17503182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rome III functional constipation and irritable bowel syndrome with constipation are similar disorders within a spectrum of sensitization, regulated by serotonin.
    Shekhar C; Monaghan PJ; Morris J; Issa B; Whorwell PJ; Keevil B; Houghton LA
    Gastroenterology; 2013 Oct; 145(4):749-57; quiz e13-4. PubMed ID: 23872499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Splitting irritable bowel syndrome: from original Rome to Rome II criteria.
    Mearin F; Roset M; Badía X; Balboa A; Baró E; Ponce J; Díaz-Rubio M; Caldwell E; Cucala M; Fueyo A; Talley NJ
    Am J Gastroenterol; 2004 Jan; 99(1):122-30. PubMed ID: 14687153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rome III vs Rome IV criteria for irritable bowel syndrome: A comparison of clinical characteristics in a large cohort study.
    Vork L; Weerts ZZRM; Mujagic Z; Kruimel JW; Hesselink MAM; Muris JWM; Keszthelyi D; Jonkers DMAE; Masclee AAM
    Neurogastroenterol Motil; 2018 Feb; 30(2):. PubMed ID: 28804974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of the Diary for Irritable Bowel Syndrome Symptoms to Assess Treatment Benefit in Clinical Trials: Foundational Qualitative Research.
    Fehnel SE; Ervin CM; Carson RT; Rigoni G; Lackner JM; Coons SJ;
    Value Health; 2017 Apr; 20(4):618-626. PubMed ID: 28408004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the irritable bowel syndrome severity index in Japanese male patients with irritable bowel syndrome with diarrhea.
    Ida M; Nishida A; Akiho H; Nakashima Y; Matsueda K; Fukudo S
    Biopsychosoc Med; 2017; 11():7. PubMed ID: 28293280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantifying Rome symptoms for diagnosis of the irritable bowel syndrome.
    Chang JY; Almazar AE; Richard Locke G; Larson JJ; Atkinson EJ; Talley NJ; Saito YA
    Neurogastroenterol Motil; 2018 Sep; 30(9):e13356. PubMed ID: 29701271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of two natural medicine formulations on irritable bowel syndrome symptoms: a pilot study.
    Hawrelak JA; Myers SP
    J Altern Complement Med; 2010 Oct; 16(10):1065-71. PubMed ID: 20954962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irritable bowel syndrome subtypes according to bowel habit: revisiting the alternating subtype.
    Mearin F; Balboa A; Badía X; Baró E; Caldwell E; Cucala M; Díaz-Rubio M; Fueyo A; Ponce J; Roset M; Talley NJ
    Eur J Gastroenterol Hepatol; 2003 Feb; 15(2):165-72. PubMed ID: 12560761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abdominal bloating is the most bothersome symptom in irritable bowel syndrome with constipation (IBS-C): a large population-based Internet survey in Japan.
    Kanazawa M; Miwa H; Nakagawa A; Kosako M; Akiho H; Fukudo S
    Biopsychosoc Med; 2016; 10():19. PubMed ID: 27274765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classification of pediatric functional gastrointestinal disorders related to abdominal pain using Rome III vs. Rome IV criterions.
    Edwards T; Friesen C; Schurman JV
    BMC Gastroenterol; 2018 Mar; 18(1):41. PubMed ID: 29549882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of a Chinese Herbal Medicine in Providing Adequate Relief of Constipation-predominant Irritable Bowel Syndrome: A Randomized Controlled Trial.
    Bensoussan A; Kellow JE; Bourchier SJ; Fahey P; Shim L; Malcolm A; Boyce P
    Clin Gastroenterol Hepatol; 2015 Nov; 13(11):1946-54.e1. PubMed ID: 26133902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.
    Evans BW; Clark WK; Moore DJ; Whorwell PJ
    Cochrane Database Syst Rev; 2007 Oct; (4):CD003960. PubMed ID: 17943807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials.
    Rahimi R; Nikfar S; Abdollahi M
    Clin Ther; 2008 May; 30(5):884-901. PubMed ID: 18555935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced Symptoms of Post-Traumatic Stress Disorder and Irritable Bowel Syndrome Following Mindfulness-Based Stress Reduction Among Veterans.
    Harding K; Simpson T; Kearney DJ
    J Altern Complement Med; 2018 Dec; 24(12):1159-1165. PubMed ID: 30160516
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of irritable bowel syndrome.
    Trinkley KE; Nahata MC
    J Clin Pharm Ther; 2011 Jun; 36(3):275-82. PubMed ID: 21545610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.